Matched Placebo (Capsules): Clinical Trials

4 trials of Matched Placebo (Capsules), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 not yet recruiting, 1 completed. 4 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Not yet recruiting 3, Completed 1
Phase 11Not yet recruiting 1
Phase 31Completed 1

Follow Matched Placebo (Capsules): new trials by email Literature Review of Matched Placebo (Capsules) trials Research Report on Matched Placebo (Capsules)

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
LiO-AD: Lithium Orotate in Alzheimers Disease Feasibility, Biomarker Engagement, and Clinical Response
Lithium orotate, Matched Placebo (Capsules) - Alzheimer s Disease
Phase 1 / Phase 2Not yet recruitingJohns Hopkins University402026-12-012026-10-07
Modulation of Stem Cell Differentiation in Individuals With High Risk Clonal Haematopoiesis
Oral Decitabine and Tetrahydrouridine, Matched Placebo (Capsules) - Clonal Cytopenia of Uncertain Significance, CCUS Clonal Cytopenia of Undetermined Significance
Phase 2Not yet recruitingClinical Hub for Interventional Research (CHOIR)802026-12-012026-11-04
Nicotinamide Riboside Supplementation in Chronic Kidney Disease
Nicotinamide Riboside (NR), Matched Placebo (Capsules) - Chronic Kidney Disease
Phase 2Not yet recruitingUniversity of California, San Diego302026-10-012026-07-15
To Study the Efficacy and Safety of Doxercalciferol on Spinal and Femoral Density in Postmenopausal Osteopenic Women in a Long Term 2 Year Study
doxercalciferol capsules, Hectorol®, Matched Placebo (Capsules) - Osteoporosis (Senile)
Phase 2 / Phase 3CompletedCreighton University601989-11-142026-07-01

Conditions studied

Osteoporosis (1)  ·  Renal Insufficiency, Chronic (1)

Sponsors

Clinical Hub for Interventional Research (CHOIR) (1)  ·  Creighton University (1)  ·  Johns Hopkins University (1)  ·  University of California, San Diego (1)

Countries

United States (2)  ·  Australia (1)

Top investigators

Armin Ahmadi, PhD (1)  ·  Christopher Morrow, MD, MHS (1)

Results publications

PMID 42564695

NIH funding

K01DK147652 (1)